Quad Technologies has opened a new, larger headquarters and laboratory that allows the company to expand manufacturing capabilities and offer clients cGMP QuickGel orders to produce reagents for gene-modified cell therapy bioprocesses.
“This new headquarters changes the game for Quad Technologies and its customers,” Kevlahan said. “We are delivering a service and product that no other company currently offers: a unique T-cell activation reagent using patented QuickGel that ensures optimal efficiency and effectiveness. By moving into this larger office and laboratory space with ISO 8 and ISO 7 clean rooms, we are poised for immediate expansion that benefits the biotechnology industry.”
With staff expected to grow 60-70% over the next 12 months, Quad Technologies is positioning itself to be a market leader through the use of novel processes and proprietary patented technologies.